apl. Prof. Dr. Markus Heppt

Medizinische Fakultät Department of Dermatology

Evaluation of Melanoma Prediction Studies Using the Prediction Model Risk of Bias Assessment Tool (PROBAST) (2022) Kaiser I, Mathes S, Pfahlberg A, Uter W, Heppt M, Steeb T, Diehl K, Gefeller O Conference contribution Decision Conflicts in Clinical Care during COVID-19: A Multi-Perspective Inquiry. (2022) Haier J, Beller J, Adorjan K, Bleich S, De Greck M, Griesinger F, Heppt M, et al. Journal article Inhibition of Melanoma Cell-Intrinsic Tim-3 Stimulates MAPK-Dependent Tumorigenesis. (2022) Schatton T, Itoh Y, Martins C, Rasbach E, Singh P, Silva M, Mucciarone K, et al. Journal article The need for regular training in skin cancer screening: a cross-sectional study among general practitioners in Germany (2022) Steeb T, Reinhardt L, Strasser C, Wessely A, Schelling J, Petzold A, Heppt M, et al. Journal article Spontaneous regression rates of actinic keratosis: a systematic review and pooled analysis of randomized controlled trials. (2022) Steeb T, Petzold A, Hornung A, Wessely A, Berking C, Heppt M Journal article Assessment of the Quality, Understandability, and Reliability of YouTube Videos as a Source of Information on Basal Cell Carcinoma:Web-Based Analysis (2022) Steeb T, Reinhardt L, Harlaß M, Heppt M, Meier F, Berking C Journal article HDAC2 Is Involved in the Regulation of BRN3A in Melanocytes and Melanoma (2022) Heppt M, Wessely A, Hornig E, Kammerbauer C, Graf SA, Besch R, French LE, et al. Journal article Increasing Participation Rates in Germany's Skin Cancer Screening Program (HELIOS): Protocol for a Mixed Methods Study (2021) Steeb T, Heppt M, Erdmann M, Wessely A, Klug SJ, Berking C Journal article c-Kit inhibitors for unresectable or metastatic mucosal, acral or chronically sun-damaged melanoma: a systematic review and one-arm meta-analysis (2021) Steeb T, Wessely A, Petzold A, Kohl C, Erdmann M, Berking C, Heppt M Journal article, Review article DIVERSITY OF CD4(+) BLOOD T-CELL CLONALITY PREDICTS LONGER SURVIVAL WITH CTLA4 OR PD-1 CHECKPOINT INHIBITION IN ADVANCED MELANOMA (2021) Arakawa A, Vollmer S, Tietze J, Galinski A, Heppt M, Berking C, Prinz JC Conference contribution